Dr. Dana Lambert left hospital pharmacy in 2013 to study cannabinoid pharmacology, learned plant medicine from indigenous elders, and bet her career on the whole plant. A new Oxford-published study shows two cannabinoids most dispensary customers have never asked for, CBC and CBG, can make silver work 64 times harder against MRSA, E. coli and Pseudomonas.
“I asked the cannabis plant (yes, I asked the plant itself, as recommended by the elders) to create better medicine.”
That is not a sentence you expect from a woman with a PhD in pharmaceutical sciences who runs a biotech company. Dr. Dana Lambert wrote it herself, in a personal essay published earlier this year. She meant it literally.
The contradiction is the point.
From the bedside to the lab
Lambert grew up on Vancouver Island, started a business degree at the University of British Columbia at 17, then transferred to pharmaceutical sciences when she realized she cared more about the chemistry of medicine than the business of it. She graduated as a licensed pharmacist in 2010 and went to work in hospitals. The job lasted two and a half years.
“I saw firsthand at patients’ bedsides the suffering, and too often, the mortality, caused by cancer, treatment-resistant infections, non-healing wounds, and chronic pain,” she wrote. “My job was to optimize drug therapy for patients, but all too often, the available treatments fell short.”
She left clinical pharmacy in 2013 and went back to UBC for a PhD in cannabinoid pharmacology. During her training she had also studied with indigenous elders on Vancouver Island and in Central America. One teaching stayed with her.
A woman with esophageal cancer who had failed chemotherapy with paclitaxel, a drug derived from Pacific yew bark, was reportedly cured after drinking tea prepared by an elder using the whole bark. The single isolated compound …
Read More
Author: Javier Hasse / High Times
